This year we celebrate our 25th year as a JSE Limited-listed company. The associated theme follows throughout our Integrated Report as we demonstrate our commitment to providing access to high quality, affordable medicines over this period, thereby enabling everyone to live a healthy and fulfilled life. This commitment is also aligned to the World Health Organization’s (“WHO’s”) promotion of Universal Health Coverage and we are committed to advancing the goals and outcomes of the United Nations SDG3 of “ensuring healthy lives and promoting well-being for all at all ages”.
Further, we believe that our industry position as a global pharmaceutical company, with a relevant portfolio of medicines and strategic manufacturing capability, is the most fundamental way in which we contribute to increasing access to medicines and furthering the global goal of universal access to healthcare.
Our ethos Healthcare. We Care. is the cornerstone of our philosophy which has driven strategic mergers and acquisitions that have created scope for global expansion, an enhanced therapeutic product portfolio and multi-continental state of the art manufacturing capabilities over 25 years.
We optimise our performance by pulling together. Our combined capabilities exceed the sum of each individual.
We constantly search for better ways of doing things and are solution oriented.
We go the extra mile, seeking to exceed expectations.
We strive to be the best we can be and to deliver to the highest standards.
Our integrity is not negotiable.
To deliver value to our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines globally.
Defining the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.
To improve the health and quality of life of patients.
